EXPERIENCE WITH TOCILIZUMAB, AN INTERLEUKIN 6 INHIBITOR, USED FOR THE TREATMENT OF GIANT CELL ARTERITIS WITH SEVERE COMORBIDITY
Giant cell arteritis (GCA), formerly known as Horton's disease, is among the most common diseases from a group of systemic vasculitides; its clinical significance is complemented with the potential involvement of the coronary arteries, aorta, and cranial arteries with development of ischemic optic n...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Russo |
| Опубліковано: |
IMA PRESS LLC
2018-05-01
|
| Серія: | Научно-практическая ревматология |
| Предмети: | |
| Онлайн доступ: | https://rsp.mediar-press.net/rsp/article/view/2529 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|